Eyebright Medical Technology Beijing Co Ltd
SSE:688050
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
65.69
195.3119
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Eyebright Medical Technology Beijing Co Ltd
Net Margin
Eyebright Medical Technology Beijing Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 16.5B CNY |
| Net Margin |
31%
|
| Country | JP |
| Market Cap | 6.8T JPY |
| Net Margin |
24%
|
| Country | CH |
| Market Cap | 37.9B CHF |
| Net Margin |
12%
|
| Country | DK |
| Market Cap | 200.9B DKK |
| Net Margin |
19%
|
| Country | US |
| Market Cap | 16.9B USD |
| Net Margin |
11%
|
| Country | KR |
| Market Cap | 9.9T KRW |
| Net Margin |
-358%
|
| Country | CA |
| Market Cap | 6.9B USD |
| Net Margin |
-8%
|
| Country | CN |
| Market Cap | 48.6B CNY |
| Net Margin |
42%
|
| Country | US |
| Market Cap | 6.3B USD |
| Net Margin |
29%
|
| Country | US |
| Market Cap | 6.1B USD |
| Net Margin |
9%
|
| Country | UK |
| Market Cap | 4.8B GBP |
| Net Margin |
7%
|
Eyebright Medical Technology Beijing Co Ltd
Glance View
Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing and currently employs 579 full-time employees. The company went IPO on 2020-07-29. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The firm conducts its businesses in domestic and overseas markets.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Eyebright Medical Technology Beijing Co Ltd's most recent financial statements, the company has Net Margin of 30.7%.
You don't have any saved screeners yet
